QuadraMed Corporation Board Subject to Investigation

An analysis on account of accepted investors QuadraMed Corporation (Public, NASDAQ:QDHC), who purchased the QDHC shares afore December 08, 2009, over abeyant breaches of fiduciary assignment and added violations of accompaniment law in affiliation with an declared arbitrary takeover amount was announced.

Those who currently are investors in shares of QuadraMed Corporation (NASDAQ:QDHC), and purchased the shares afore December 08, 2009, and / or accept added advice apropos to the investigation, should acquaintance the Shareholders Foundation, Inc. at mail(at)shareholdersfoundation.com or at: +1 (858) 779 - 1554.

The analysis by a law close focus on abeyant breaches of fiduciary assignment and added violations of accompaniment law by the Board of Directors of QuadraMed Corp. arising out of their attack to advertise QuadraMed Corporation to Francisco Partners. On December 08, 2009, QuadraMed Corporation (NASDAQ:QDHC) appear that it has entered into a absolute alliance acceding to be acquired by Francisco Partners. Under the agreement of the acceding Francisco Partners has agreed to access all of the outstanding shares of QuadraMed’s accepted banal (QDHC) for $8.50 per allotment in banknote and all of the outstanding shares of QuadraMed’s Series A Cumulative Mandatory Convertible Preferred Stock for $13.7097 per allotment in cash. According to QuadraMed the all-cash transaction is admired at about $126 actor and the proposed acquirement amount per allotment of accepted banal represents a exceptional of about 32.6% to the closing allotment amount of QuadraMed’s accepted banal on December 7, 2009, the endure trading day above-mentioned to the accessible advertisement of the transaction, a exceptional of about 33.3% to the 30-day abaft boilerplate closing amount of QuadraMed’s accepted stock, and a exceptional of about 7.1% to the 52-week-high closing amount of QuadraMed’s accepted stock.

But according to an analysis by a law close “the transaction appears to be unfair” to accepted investors of QuadraMed Corporation (NASDAQ:QDHC) because the “offer to acquirement QuadraMed Corporation (QDHC) appears opportunistically timed to crop advantage of the accepted bread-and-butter downturn” and is “grossly unfair, inadequate, and essentially below the fair or inherent amount of QDHC”. The analysis “concerns whether the QuadraMed Corporation Board of Directors aperture their fiduciary duties to QuadraMed (QDHC) shareholders by accordant to advertise the QDHC at an arbitrary amount thereby harming QuadraMed Corporation and its shareholders”, “whether the admiral of QuadraMed Corp. may accept breached their fiduciary duties by not acting in QDHC shareholders' best interests” “given that the action amount is alone a baby exceptional over the $7.94 amount the Company's shares traded at as afresh as October 14, 2009 and at atomic one analyst set a amount ambition for QuadraMed banal at $11.00 per share” and “the Company may not accept abundantly shopped itself about afore entering into this transaction and, pursuant to this proposed transaction, Francisco Partners may be underpaying for QuadraMed Corporation, appropriately unlawfully harming QDHC shareholders”. Shares of QuadraMed Corporation (QDHC) traded at $8.32per allotment afterwards the advertisement and at about $6.75 per allotment the day afore the news. QDHC shares traded in 2008 at over $10 per allotment and in 2007 at over $15 per share. QuadraMed Corporation, Reston, VA, provides healthcare advice technology (HIT) to hospitals and added healthcare organizations. Its solutions are acclimated by organizations, such as hospitals, which includes association hospitals, bookish hospitals, bounded and bounded accumulation networks, hospital-based clinics, and authoritative agencies. QuadraMed Corporation appear in 2007 Total Revenue of $137.35million with a Net Income of $63million and in 2008 Total Revenue of $150.44million with a Net assets of $7.17million.